Multidisciplinary Head and Neck Cancers Symposium 2022

• Comprehensive Rehabilitation of the Head and Neck Patient
  • Heather Starmer, MA, CCC-SLP, BCS-S, Stanford University, Stanford, California [SLP]
• Oral/Dental Needs in HNC Survivors
  • Joel Epstein, DMD, MSD, Cedars-Sinai, Los Angeles [OMFS]
• Addressing the Psychological Aspects of Head and Neck Cancer
  • Elizabeth Cash, PhD, University of Louisville, Louisville, Kentucky [Psychologist]
• The Artistry of Facial Prosthetics
  • Devin Okay, DDS, Mount Sinai Hospital, New York [OMFS]
• Nutrition in Head and Neck Cancer
  • Patricia Rubio, MBA, MS, University of California, San Diego [Nutritionist]
• Questions and Answers

• Sharon Spencer, MD, University of Alabama at Birmingham, Birmingham, Alabama [R]
• Charles Moore, MD, Emory University, Atlanta [HNS]

• Immunotherapy in the Curative Intent Setting
  • Sana Karam, MD, PhD, University of Colorado, Denver [R]
• The Role of Preop IO in Locally Advanced HNC
  • Ravi Uppaluri, MD, PhD, Brigham and Women’s Hospital, Boston [HNS]
• Novel Radiosensitizers
  • Heath Skinner, MD, PhD, University of Pittsburgh,  Pittsburgh [R]​
• Nasopharynx: Induction vs Adjuvant – Where do we go from here?
  • Dimitrios Colevas, MD, Stanford University, Stanford, California [M]
• Questions and Answers

Early-career and Trainee Networking Luncheon: Choosing Your Career Path
Highlight careers briefly at the beginning and then break out into small groups at the different round tables.
Moderator: Maie St. John, MD, PhD, UCLA David Geffen, Los Angeles [HNS]

• Julie Bauman, MD, MPH, University of Arizona, Tucson, Arizona [M]
• Katherine Hutcheson, PhD, MD Anderson Cancer Center, Houston [Speech Path]
• Faye Johnson, MD, PhD, MD Anderson Cancer Center, Houston [M]
• Loren Mell, MD, University of California, San Diego [R]
• Maie St. John, MD, PhD, UCLA David Geffen, Los Angeles [HNS]

• Early Toxicity and Patient Reported Outcomes from a Phase 2 Trial of FDG-PET Response-based De-escalated Definitive Radiotherapy for p16+ Oropharynx Cancer
  • Steven Allen, University of Michigan, Ann Arbor, Michigan
• Non-inferiority Margin and Nodal Analysis of De-escalated Adjuvant Radiation Therapy (DART) for HPV-related Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Preplanned Pooled Analysis of MC1273 & MC1675
  • Daniel Ma, Mayo Clinic, Rochester, Minnesota
• Detection of Occult Recurrence Using Circulating HPV Tumor DNA among Patients Treated for HPV-driven Oropharyngeal Squamous Cell Carcinoma
  • Glenn Hanna, Dana-Farber Cancer Institute, Harvard Medical School, Boston
• Kinetics of Circulating Human Papillomavirus (cHPV) DNA in Plasma and Oral Gargles from Patients with HPV-positive Oropharyngeal Cancer (OPC) Treated with Definitive Radiation Therapy
  • Michelle Echevarria, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
• A Clinically Translatable, Extensively Validated Immune-based Classification of Human Papillomavirus-associated Head and Neck Cancer with Implications for Treatment Deintensification and Immunotherapy
  • Peter Zeng, Western University, London, Ontario, Canada
• Predicted Th2 Infiltrate is Associated with Outcome in HPV(-) Head and Neck Cancer
  • Mohamed Abdelhakiem, UPMC Hillman Cancer Center, Pittsburgh
• Loss of HPV 16- E2 Predicts Disease Free Survival and Promotes Platinum Resistance in Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma
  • Molly Heft-Neal, University of Michigan, Ann Arbor, Michigan
• Neoadjuvant Immunoradiotherapy in a Tobacco-Signature Preclinical Oral Squamous Cell Carcinoma Model
  • Robert Saddawi-Konefka, University of California, San Diego
• HPV E5 Mediates Resistance to PD-1 Checkpoint Blockade via Inhibition of MHC and IFN Pathway
  • Andrew Sharabi, University of California, San Diego

• Susan McCammon, MD, University of Alabama, Birmingham, Birmingham, Alabama [HNS]
• Loren Mell, MD, University of California, San Diego [R]
• Paul Loren Swiecicki, MD, University of Michigan, Ann Arbor, Michigan [M]
• Questions and Answers

• Tumor Board
• Intraoperative Margin Assessment
  • Mark Varvares, MD, FACS, Massachusetts General Hospital, Boston [HNS]
• Pathologist’s Perspective
  • Margaret Brandwein-Weber, MD, Mount Sinai, New York [Pathologist]
• Sentinel Node and Neck Dissection
  • Stephen Lai, MD, PhD, FACS, MD Anderson Cancer Center, Houston [HNS]
• New Frontiers in Sx: Fluorescence Guided Sx
  • Eben Rosenthal, MD, Vanderbilt University Medical Center, Nashville [HNS]
• Surgical Reconstruction
  • Kelly Malloy, MD, University of Michigan, Ann Arbor, Michigan [HNS]

• An Artificial Intelligence Ultrasound Platform for Screening and Staging of Thyroid Cancer
  • Annie Chan, Massachusetts General Hospital, Harvard Medical School, Boston
• Development of a Deep Learning-based Auto-segmentation of Organs at Risk for Head and Neck Radiotherapy Planning
  • Jihye Koo, University of South Florida, Tampa, Florida
• Safety and Efficacy of RP1 + Nivolumab in Patients with Non-melanoma Skin Cancer of the Head and Neck: Results From IGNYTE Phase 1/2 Multi-cohort Clinical Trial
  • Jiaxin Niu, Banner MD Anderson Cancer Center, Houston
• A Novel Intratumoral Microdosing Approach for Simultaneously Evaluating Multiple Drugs and Combinations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Harrison Cash, University of Washington Medical Center, Seattle
• Efficacy and Safety of Tisotumab Vedotin in Patients with Head and Neck Squamous Cell Carcinoma: Results from a Phase II Cohort
  • May Cho, MD, University of California, Irvine, CA
• Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Carcinoma: Results from the Phase II LT-SABR Study
  • David Sher, University of Texas Southwestern Medical Center, Dallas
• Standard but Not Equal: Disparities in Advanced Radiotherapy Techniques for Head and Neck Cancer in the United States
  • Neal McCall, Winship Cancer Institute of Emory University, Atlanta
• Focal Adhesion Kinase Drives Resistance to Therapy in HPV-Negative Head and Neck Squamous Cell Carcinoma in a P53-Dependent Manner
  • Phillip Pifer, UPMC Hillman Cancer Center, Pittsburgh

Early-career and Trainee Networking Luncheon: Launching Your Successful Career

• How to Get Your Paper Published
  • Renata Ferrarotto, MD, MD Anderson Cancer Center, Houston, Texas [M]
• Finding Personal/Professional Balance
  • Cherie-Ann Nathan, MD, Louisiana State University-Health, Shreveport, Louisiana [HNS]
• Seeking Out and Maintaining Mentoring Relationships
  • Zain Husain, MD, Sunnybrook Health Sciences Centre, Ontario, Canada [Dermatologist]

• Mutational Landscape of Thyroid Cancers
  • Nabil Saba, MD, FACP, Winship Cancer Institute of Emory University, Atlanta [M]
• Low Risk Thyroid Cancer/RAI
  • Jennifer Sipos, MD, The Ohio State University, Columbus, Ohio [Endocrinologist]
• Therapies for High Risk and Anaplastic Thyroid Cancer
  • Saad Khan, MD, Stanford University, Stanford, California [M]
• Multimodality Therapy for Aggressive Differentiated Thyroid Cancers
  • Mark Zafereo, MD, FACS, MD Anderson Cancer Center, Houston [HNS]

• Controversies in Surgical Management
  • Cecelia Schmalbach, MD, MSc, FACS, Temple Health, Philadelphia [HNS]
• Role of Radiation
  • ​Shlomo Koyfman, MD, Cleveland Clinic, Cleveland [R]
• Systemic Therapy
  • Jessica Geiger, MD, Cleveland Clinic Cancer Center, Cleveland [M
• Immunotherapy in Special Populations
  • Anne Chang, MD, Stanford University, Stanford, California [Dermatologist]
• Questions and Answers

• Developing Care Pathways
  • Liza Blumenfeld, MA, CCC-SLP, BCS-S, University of California, San Diego [SLP]
• Practice and Research
  • Marci Lee Nilsen, PhD, RN, University of Pittsburgh, Pittsburgh [RN]
• Financial Toxicity
  • Jonas de Souza, MD, MBA, HCA Healthcare, Nashville [M]
• Questions and Answers

• Introduction
  • Katherine Hutcheson, PhD, MD Anderson Cancer Center, Houston [SLP]
• Surgical Considerations
  • Umamaheswar Duvvuri, MD, PhD, University of Pittsburgh, Pittsburgh [HNS]
• Radiation Considerations
  • Bhisham Chera, MD, UNC School of Medicine, Chapel Hill, North Carolina [R]
• Systemic Considerations
  • Neil Hayes, MD, The University of Tennessee Health Science Center, Memphis, Tennessee [M]
• Questions and Answers

• Current Approaches to Managing Salivary Cancer
  • Kiran Kakarala, MD, University of Kansas Medical Center, Kansas City, Kansas [HNS]
• Novel Systemic Treatment for Recurrent or Metastatic Salivary Cancers
  • Renata Ferrarotto, MD, MD Anderson Cancer Center, Houston [M]
• Questions and Answers

• Re-irradiation for Recurrent and Second Primary Head and Neck Cancers
  • Neal Dunlap, MD, University of Louisville, Louisville, Kentucky [R] ​
• Surgical Salvage with Reconstruction
  • Urjeet Patel, MD, Northwestern Hospital, Chicago [HNS]
• Novel Targeted and Immunotherapies
  • Christine Chung, MD, Moffitt Cancer Center, Tampa, Florida [M]
• Case Discussions